T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
BorgWarner
BWA
$13.8B
| $10.6M | ﹤0.01% |
385,017
+3,831
| +1% | +$124K |
|
1052
MeiraGTx Holdings
MGTX
$1.17B
| $10.6M | ﹤0.01% |
1,255,066
-536,225
| -30% | -$4.73M |
|
1053
BWX Technologies
BWXT
$15.6B
| $10.5M | ﹤0.01% |
209,313
-7,556,067
| -97% | -$408M |
|
1054
The Bancorp
TBBK
$2.82B
| $10.4M | ﹤0.01% |
473,093
+4,095
| +0.9% | +$94.9K |
|
|
ALTR
1055
DELISTED
Altair Engineering Inc
ALTR
| $10.3M | ﹤0.01% |
232,282
-73,407
| -24% | -$3.85M |
|
1056
Selective Insurance
SIGI
$5.59B
| $10.2M | ﹤0.01% |
125,697
-2,787,716
| -96% | -$227M |
|
1057
Qorvo
QRVO
$8.68B
| $10.2M | ﹤0.01% |
128,508
-10,032
| -7% | -$970K |
|
1058
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| – | – |
-552,560
| Closed | -$8.89M |
|
1059
iShares Core S&P 500 ETF
IVV
$910B
| $10M | ﹤0.01% |
24,112
+6,630
| +38% | +$2.65M |
|
1060
Brunswick
BC
$5.29B
| $10M | ﹤0.01% |
152,942
+20,334
| +15% | +$1.53M |
|
1061
Whirlpool
WHR
$2.79B
| $9.99M | ﹤0.01% |
74,073
+1,665
| +2% | +$265K |
|
1062
Dynatrace
DT
$14.7B
| $9.98M | ﹤0.01% |
286,579
-92,590
| -24% | -$3.58M |
|
1063
American Airlines Group
AAL
$9.97B
| $9.97M | ﹤0.01% |
827,695
-4,867
| -0.6% | -$67.8K |
|
|
CNTA
1064
DELISTED
Centessa Pharmaceuticals
CNTA
| $9.83M | ﹤0.01% |
2,445,983
-15,147
| -0.6% | -$69.3K |
|
|
BCYC
1065
Bicycle Therapeutics
BCYC
$279M
| $9.71M | ﹤0.01% |
417,340
-3,921
| -0.9% | -$93.3K |
|
1066
Ovintiv
OVV
$17.2B
| $9.68M | ﹤0.01% |
210,392
+45,314
| +27% | +$2.16M |
|
1067
Helen of Troy
HELE
$699M
| $9.68M | ﹤0.01% |
100,334
-4,750
| -5% | -$610K |
|
1068
Lincoln National
LNC
$8.67B
| $9.51M | ﹤0.01% |
216,447
+5,903
| +3% | +$284K |
|
1069
iShares Russell 1000 Growth ETF
IWF
$129B
| $9.5M | ﹤0.01% |
180,676
-39,964
| -18% | -$2.35M |
|
1070
Tapestry
TPR
$25.9B
| $9.49M | ﹤0.01% |
333,803
-4,963
| -1% | -$166K |
|
1071
Twilio
TWLO
$38.3B
| $9.46M | ﹤0.01% |
136,858
-3,811,528
| -97% | -$305M |
|
1072
Innovative Industrial Properties
IIPR
$1.67B
| $9.22M | ﹤0.01% |
104,196
-26,533
| -20% | -$2.57M |
|
1073
Ubiquiti
UI
$35.3B
| $9.21M | ﹤0.01% |
31,362
-2,573
| -8% | -$759K |
|
|
CCF
1074
DELISTED
Chase Corporation
CCF
| $8.99M | ﹤0.01% |
107,630
-68,548
| -39% | -$6.06M |
|
1075
Teladoc Health
TDOC
$1.26B
| $8.95M | ﹤0.01% |
353,182
+36,051
| +11% | +$1.26M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.